NU7441 is a fairly specific DNA-PKcs inhibitor that showed promising results as a radiosensitizer against nasopharyngeal and liver cancer[150,151], and low concentrations of NU7441 enhance radiosensitivity of lung cancer cells to both X-rays and carbon ions[152]. Here, PRKDC is linked to lung carcinoma.